Global Liraglutide Market Growth 2019-2024

Publisher Name :
Date: 12-Feb-2019
No. of pages: 130

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.

The total amount of Patents about Liraglutide are 1871, among those Patents, 44%is about application, 26%is about Combination therapy, and 12%is about Preparation method.

In these patents, accounting for Europe is the largest, followed by North America, and finally Asia.

The application of Liraglutide

Liraglutide for the treatment of type 2 diabetes mellitus

Liraglutide 1.2 mg daily in triple therapy regimens (in combination with metformin and a sulphonylurea, or metformin and a thiazolidinedione) is recommended as an option for the treatment of people with type 2 diabetes, only if used as described for exenatide in 'Type 2 diabetes: the management of type 2 diabetes'

Liraglutide 1.2 mg daily in dual therapy regimens (in combination with metformin or a sulphonylurea) is recommended as an option for the treatment of people with type 2 diabetes, only if the person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and the person is intolerant of thiazolidinediones and dipeptidyl peptidase-4 (DPP-4) inhibitors, or treatment with thiazolidinediones and DPP-4 inhibitors is contraindicated.

Liraglutide 1.8 mg daily is not recommended for the treatment of people with type 2 diabetes.

The Committee concluded that the evidence provided was not robust enough to allow it to recommend liraglutide as a cost-effective alternative to either thiazolidinediones or DPP-4 inhibitors as a triple therapy regimen, however it believes liraglutide is a cost-effective treatment option relative to exenatide.

Taking into account the lack of clinical trial evidence showing a significant benefit from increasing the liraglutide dose from 1.2 mg to 1.8 mg, the widely varying ICERs and the uncertainty in the economic analysis, the Committee was unable to recommend liraglutide 1.8 mg for the treatment of type 2 diabetes.

The Committee concluded that people with type 2 diabetes currently receiving liraglutide who do not meet the criteria specified in section 1.1 or 1.3, or who are receiving liraglutide 1.8 mg, should have the option to continue their current treatment until they and their clinicians consider it appropriate to stop.

According to this study, over the next five years the Liraglutide market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Liraglutide business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Liraglutide market by product type, application, key manufacturers and key regions and countries.

This study considers the Liraglutide value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

- Pills

- Liquid

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

- Hospital

- Drug Store

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- HEC Pharm

- Bachem

- Bharat Pharmaceuticals

- Kingpep Biotechnology

- Shenzhen JYMed Technology

- Wuxi Asiapeptide

- AmbioPharm

- ...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Liraglutide consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

- To understand the structure of Liraglutide market by identifying its various subsegments.

- Focuses on the key global Liraglutide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Liraglutide with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Liraglutide submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Liraglutide Market Growth 2019-2024

Table of Contents

2019-2024 Global Liraglutide Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Liraglutide Consumption 2014-2024
2.1.2 Liraglutide Consumption CAGR by Region
2.2 Liraglutide Segment by Type
2.2.1 Pills
2.2.2 Liquid
2.3 Liraglutide Consumption by Type
2.3.1 Global Liraglutide Consumption Market Share by Type (2014-2019)
2.3.2 Global Liraglutide Revenue and Market Share by Type (2014-2019)
2.3.3 Global Liraglutide Sale Price by Type (2014-2019)
2.4 Liraglutide Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.5 Liraglutide Consumption by Application
2.5.1 Global Liraglutide Consumption Market Share by Application (2014-2019)
2.5.2 Global Liraglutide Value and Market Share by Application (2014-2019)
2.5.3 Global Liraglutide Sale Price by Application (2014-2019)

3 Global Liraglutide by Players
3.1 Global Liraglutide Sales Market Share by Players
3.1.1 Global Liraglutide Sales by Players (2017-2019)
3.1.2 Global Liraglutide Sales Market Share by Players (2017-2019)
3.2 Global Liraglutide Revenue Market Share by Players
3.2.1 Global Liraglutide Revenue by Players (2017-2019)
3.2.2 Global Liraglutide Revenue Market Share by Players (2017-2019)
3.3 Global Liraglutide Sale Price by Players
3.4 Global Liraglutide Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Liraglutide Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Liraglutide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Liraglutide by Regions
4.1 Liraglutide by Regions
4.1.1 Global Liraglutide Consumption by Regions
4.1.2 Global Liraglutide Value by Regions
4.2 Americas Liraglutide Consumption Growth
4.3 APAC Liraglutide Consumption Growth
4.4 Europe Liraglutide Consumption Growth
4.5 Middle East & Africa Liraglutide Consumption Growth

5 Americas
5.1 Americas Liraglutide Consumption by Countries
5.1.1 Americas Liraglutide Consumption by Countries (2014-2019)
5.1.2 Americas Liraglutide Value by Countries (2014-2019)
5.2 Americas Liraglutide Consumption by Type
5.3 Americas Liraglutide Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Liraglutide Consumption by Countries
6.1.1 APAC Liraglutide Consumption by Countries (2014-2019)
6.1.2 APAC Liraglutide Value by Countries (2014-2019)
6.2 APAC Liraglutide Consumption by Type
6.3 APAC Liraglutide Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Liraglutide by Countries
7.1.1 Europe Liraglutide Consumption by Countries (2014-2019)
7.1.2 Europe Liraglutide Value by Countries (2014-2019)
7.2 Europe Liraglutide Consumption by Type
7.3 Europe Liraglutide Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Liraglutide by Countries
8.1.1 Middle East & Africa Liraglutide Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Liraglutide Value by Countries (2014-2019)
8.2 Middle East & Africa Liraglutide Consumption by Type
8.3 Middle East & Africa Liraglutide Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Liraglutide Distributors
10.3 Liraglutide Customer

11 Global Liraglutide Market Forecast
11.1 Global Liraglutide Consumption Forecast (2019-2024)
11.2 Global Liraglutide Forecast by Regions
11.2.1 Global Liraglutide Forecast by Regions (2019-2024)
11.2.2 Global Liraglutide Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Liraglutide Forecast by Type
11.8 Global Liraglutide Forecast by Application

12 Key Players Analysis
12.1 HEC Pharm
12.1.1 Company Details
12.1.2 Liraglutide Product Offered
12.1.3 HEC Pharm Liraglutide Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 HEC Pharm News
12.2 Bachem
12.2.1 Company Details
12.2.2 Liraglutide Product Offered
12.2.3 Bachem Liraglutide Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Bachem News
12.3 Bharat Pharmaceuticals
12.3.1 Company Details
12.3.2 Liraglutide Product Offered
12.3.3 Bharat Pharmaceuticals Liraglutide Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Bharat Pharmaceuticals News
12.4 Kingpep Biotechnology
12.4.1 Company Details
12.4.2 Liraglutide Product Offered
12.4.3 Kingpep Biotechnology Liraglutide Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Kingpep Biotechnology News
12.5 Shenzhen JYMed Technology
12.5.1 Company Details
12.5.2 Liraglutide Product Offered
12.5.3 Shenzhen JYMed Technology Liraglutide Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Shenzhen JYMed Technology News
12.6 Wuxi Asiapeptide
12.6.1 Company Details
12.6.2 Liraglutide Product Offered
12.6.3 Wuxi Asiapeptide Liraglutide Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Wuxi Asiapeptide News
12.7 AmbioPharm
12.7.1 Company Details
12.7.2 Liraglutide Product Offered
12.7.3 AmbioPharm Liraglutide Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 AmbioPharm News

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Liraglutide
Table Product Specifications of Liraglutide
Figure Liraglutide Report Years Considered
Figure Market Research Methodology
Figure Global Liraglutide Consumption Growth Rate 2014-2024 (K Units)
Figure Global Liraglutide Value Growth Rate 2014-2024 ($ Millions)
Table Liraglutide Consumption CAGR by Region 2014-2024 ($ Millions)
Figure Product Picture of Pills
Table Major Players of Pills
Figure Product Picture of Liquid
Table Major Players of Liquid
Table Global Consumption Sales by Type (2014-2019)
Table Global Liraglutide Consumption Market Share by Type (2014-2019)
Figure Global Liraglutide Consumption Market Share by Type (2014-2019)
Table Global Liraglutide Revenue by Type (2014-2019) ($ million)
Table Global Liraglutide Value Market Share by Type (2014-2019) ($ Millions)
Figure Global Liraglutide Value Market Share by Type (2014-2019)
Table Global Liraglutide Sale Price by Type (2014-2019)
Figure Liraglutide Consumed in Hospital
Figure Global Liraglutide Market: Hospital (2014-2019) (K Units)
Figure Global Liraglutide Market: Hospital (2014-2019) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure Liraglutide Consumed in Drug Store
Figure Global Liraglutide Market: Drug Store (2014-2019) (K Units)
Figure Global Liraglutide Market: Drug Store (2014-2019) ($ Millions)
Figure Global Drug Store YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2014-2019)
Table Global Liraglutide Consumption Market Share by Application (2014-2019)
Figure Global Liraglutide Consumption Market Share by Application (2014-2019)
Table Global Liraglutide Value by Application (2014-2019)
Table Global Liraglutide Value Market Share by Application (2014-2019)
Figure Global Liraglutide Value Market Share by Application (2014-2019)
Table Global Liraglutide Sale Price by Application (2014-2019)
Table Global Liraglutide Sales by Players (2017-2019) (K Units)
Table Global Liraglutide Sales Market Share by Players (2017-2019)
Figure Global Liraglutide Sales Market Share by Players in 2017
Figure Global Liraglutide Sales Market Share by Players in 2018
Table Global Liraglutide Revenue by Players (2017-2019) ($ Millions)
Table Global Liraglutide Revenue Market Share by Players (2017-2019)
Figure Global Liraglutide Revenue Market Share by Players in 2017
Figure Global Liraglutide Revenue Market Share by Players in 2018
Table Global Liraglutide Sale Price by Players (2017-2019)
Figure Global Liraglutide Sale Price by Players in 2018
Table Global Liraglutide Manufacturing Base Distribution and Sales Area by Players
Table Players Liraglutide Products Offered
Table Liraglutide Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Liraglutide Consumption by Regions 2014-2019 (K Units)
Table Global Liraglutide Consumption Market Share by Regions 2014-2019
Figure Global Liraglutide Consumption Market Share by Regions 2014-2019
Table Global Liraglutide Value by Regions 2014-2019 ($ Millions)
Table Global Liraglutide Value Market Share by Regions 2014-2019
Figure Global Liraglutide Value Market Share by Regions 2014-2019
Figure Americas Liraglutide Consumption 2014-2019 (K Units)
Figure Americas Liraglutide Value 2014-2019 ($ Millions)
Figure APAC Liraglutide Consumption 2014-2019 (K Units)
Figure APAC Liraglutide Value 2014-2019 ($ Millions)
Figure Europe Liraglutide Consumption 2014-2019 (K Units)
Figure Europe Liraglutide Value 2014-2019 ($ Millions)
Figure Middle East & Africa Liraglutide Consumption 2014-2019 (K Units)
Figure Middle East & Africa Liraglutide Value 2014-2019 ($ Millions)
Table Americas Liraglutide Consumption by Countries (2014-2019) (K Units)
Table Americas Liraglutide Consumption Market Share by Countries (2014-2019)
Figure Americas Liraglutide Consumption Market Share by Countries in 2018
Table Americas Liraglutide Value by Countries (2014-2019) ($ Millions)
Table Americas Liraglutide Value Market Share by Countries (2014-2019)
Figure Americas Liraglutide Value Market Share by Countries in 2018
Table Americas Liraglutide Consumption by Type (2014-2019) (K Units)
Table Americas Liraglutide Consumption Market Share by Type (2014-2019)
Figure Americas Liraglutide Consumption Market Share by Type in 2018
Table Americas Liraglutide Consumption by Application (2014-2019) (K Units)
Table Americas Liraglutide Consumption Market Share by Application (2014-2019)
Figure Americas Liraglutide Consumption Market Share by Application in 2018
Figure United States Liraglutide Consumption Growth 2014-2019 (K Units)
Figure United States Liraglutide Value Growth 2014-2019 ($ Millions)
Figure Canada Liraglutide Consumption Growth 2014-2019 (K Units)
Figure Canada Liraglutide Value Growth 2014-2019 ($ Millions)
Figure Mexico Liraglutide Consumption Growth 2014-2019 (K Units)
Figure Mexico Liraglutide Value Growth 2014-2019 ($ Millions)
Table APAC Liraglutide Consumption by Countries (2014-2019) (K Units)
Table APAC Liraglutide Consumption Market Share by Countries (2014-2019)
Figure APAC Liraglutide Consumption Market Share by Countries in 2018
Table APAC Liraglutide Value by Countries (2014-2019) ($ Millions)
Table APAC Liraglutide Value Market Share by Countries (2014-2019)
Figure APAC Liraglutide Value Market Share by Countries in 2018
Table APAC Liraglutide Consumption by Type (2014-2019) (K Units)
Table APAC Liraglutide Consumption Market Share by Type (2014-2019)
Figure APAC Liraglutide Consumption Market Share by Type in 2018
Table APAC Liraglutide Consumption by Application (2014-2019) (K Units)
Table APAC Liraglutide Consumption Market Share by Application (2014-2019)
Figure APAC Liraglutide Consumption Market Share by Application in 2018
Figure China Liraglutide Consumption Growth 2014-2019 (K Units)
Figure China Liraglutide Value Growth 2014-2019 ($ Millions)
Figure Japan Liraglutide Consumption Growth 2014-2019 (K Units)
Figure Japan Liraglutide Value Growth 2014-2019 ($ Millions)
Figure Korea Liraglutide Consumption Growth 2014-2019 (K Units)
Figure Korea Liraglutide Value Growth 2014-2019 ($ Millions)
Figure Southeast Asia Liraglutide Consumption Growth 2014-2019 (K Units)
Figure Southeast Asia Liraglutide Value Growth 2014-2019 ($ Millions)
Figure India Liraglutide Consumption Growth 2014-2019 (K Units)
Figure India Liraglutide Value Growth 2014-2019 ($ Millions)
Figure Australia Liraglutide Consumption Growth 2014-2019 (K Units)
Figure Australia Liraglutide Value Growth 2014-2019 ($ Millions)
Table Europe Liraglutide Consumption by Countries (2014-2019) (K Units)
Table Europe Liraglutide Consumption Market Share by Countries (2014-2019)
Figure Europe Liraglutide Consumption Market Share by Countries in 2018
Table Europe Liraglutide Value by Countries (2014-2019) ($ Millions)
Table Europe Liraglutide Value Market Share by Countries (2014-2019)
Figure Europe Liraglutide Value Market Share by Countries in 2018
Table Europe Liraglutide Consumption by Type (2014-2019) (K Units)
Table Europe Liraglutide Consumption Market Share by Type (2014-2019)
Figure Europe Liraglutide Consumption Market Share by Type in 2018
Table Europe Liraglutide Consumption by Application (2014-2019) (K Units)
Table Europe Liraglutide Consumption Market Share by Application (2014-2019)
Figure Europe Liraglutide Consumption Market Share by Application in 2018
Figure Germany Liraglutide Consumption Growth 2014-2019 (K Units)
Figure Germany Liraglutide Value Growth 2014-2019 ($ Millions)
Figure France Liraglutide Consumption Growth 2014-2019 (K Units)
Figure France Liraglutide Value Growth 2014-2019 ($ Millions)
Figure UK Liraglutide Consumption Growth 2014-2019 (K Units)
Figure UK Liraglutide Value Growth 2014-2019 ($ Millions)
Figure Italy Liraglutide Consumption Growth 2014-2019 (K Units)
Figure Italy Liraglutide Value Growth 2014-2019 ($ Millions)
Figure Russia Liraglutide Consumption Growth 2014-2019 (K Units)
Figure Russia Liraglutide Value Growth 2014-2019 ($ Millions)
Figure Spain Liraglutide Consumption Growth 2014-2019 (K Units)
Figure Spain Liraglutide Value Growth 2014-2019 ($ Millions)
Table Middle East & Africa Liraglutide Consumption by Countries (2014-2019) (K Units)
Table Middle East & Africa Liraglutide Consumption Market Share by Countries (2014-2019)
Figure Middle East & Africa Liraglutide Consumption Market Share by Countries in 2018
Table Middle East & Africa Liraglutide Value by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Liraglutide Value Market Share by Countries (2014-2019)
Figure Middle East & Africa Liraglutide Value Market Share by Countries in 2018
Table Middle East & Africa Liraglutide Consumption by Type (2014-2019) (K Units)
Table Middle East & Africa Liraglutide Consumption Market Share by Type (2014-2019)
Figure Middle East & Africa Liraglutide Consumption Market Share by Type in 2018
Table Middle East & Africa Liraglutide Consumption by Application (2014-2019) (K Units)
Table Middle East & Africa Liraglutide Consumption Market Share by Application (2014-2019)
Figure Middle East & Africa Liraglutide Consumption Market Share by Application in 2018
Figure Egypt Liraglutide Consumption Growth 2014-2019 (K Units)
Figure Egypt Liraglutide Value Growth 2014-2019 ($ Millions)
Figure South Africa Liraglutide Consumption Growth 2014-2019 (K Units)
Figure South Africa Liraglutide Value Growth 2014-2019 ($ Millions)
Figure Israel Liraglutide Consumption Growth 2014-2019 (K Units)
Figure Israel Liraglutide Value Growth 2014-2019 ($ Millions)
Figure Turkey Liraglutide Consumption Growth 2014-2019 (K Units)
Figure Turkey Liraglutide Value Growth 2014-2019 ($ Millions)
Figure GCC Countries Liraglutide Consumption Growth 2014-2019 (K Units)
Figure GCC Countries Liraglutide Value Growth 2014-2019 ($ Millions)
Table Liraglutide Distributors List
Table Liraglutide Customer List
Figure Global Liraglutide Consumption Growth Rate Forecast (2019-2024) (K Units)
Figure Global Liraglutide Value Growth Rate Forecast (2019-2024) ($ Millions)
Table Global Liraglutide Consumption Forecast by Countries (2019-2024) (K Units)
Table Global Liraglutide Consumption Market Forecast by Regions
Table Global Liraglutide Value Forecast by Countries (2019-2024) ($ Millions)
Table Global Liraglutide Value Market Share Forecast by Regions
Figure Americas Liraglutide Consumption 2019-2024 (K Units)
Figure Americas Liraglutide Value 2019-2024 ($ Millions)
Figure APAC Liraglutide Consumption 2019-2024 (K Units)
Figure APAC Liraglutide Value 2019-2024 ($ Millions)
Figure Europe Liraglutide Consumption 2019-2024 (K Units)
Figure Europe Liraglutide Value 2019-2024 ($ Millions)
Figure Middle East & Africa Liraglutide Consumption 2019-2024 (K Units)
Figure Middle East & Africa Liraglutide Value 2019-2024 ($ Millions)
Figure United States Liraglutide Consumption 2019-2024 (K Units)
Figure United States Liraglutide Value 2019-2024 ($ Millions)
Figure Canada Liraglutide Consumption 2019-2024 (K Units)
Figure Canada Liraglutide Value 2019-2024 ($ Millions)
Figure Mexico Liraglutide Consumption 2019-2024 (K Units)
Figure Mexico Liraglutide Value 2019-2024 ($ Millions)
Figure Brazil Liraglutide Consumption 2019-2024 (K Units)
Figure Brazil Liraglutide Value 2019-2024 ($ Millions)
Figure China Liraglutide Consumption 2019-2024 (K Units)
Figure China Liraglutide Value 2019-2024 ($ Millions)
Figure Japan Liraglutide Consumption 2019-2024 (K Units)
Figure Japan Liraglutide Value 2019-2024 ($ Millions)
Figure Korea Liraglutide Consumption 2019-2024 (K Units)
Figure Korea Liraglutide Value 2019-2024 ($ Millions)
Figure Southeast Asia Liraglutide Consumption 2019-2024 (K Units)
Figure Southeast Asia Liraglutide Value 2019-2024 ($ Millions)
Figure India Liraglutide Consumption 2019-2024 (K Units)
Figure India Liraglutide Value 2019-2024 ($ Millions)
Figure Australia Liraglutide Consumption 2019-2024 (K Units)
Figure Australia Liraglutide Value 2019-2024 ($ Millions)
Figure Germany Liraglutide Consumption 2019-2024 (K Units)
Figure Germany Liraglutide Value 2019-2024 ($ Millions)
Figure France Liraglutide Consumption 2019-2024 (K Units)
Figure France Liraglutide Value 2019-2024 ($ Millions)
Figure UK Liraglutide Consumption 2019-2024 (K Units)
Figure UK Liraglutide Value 2019-2024 ($ Millions)
Figure Italy Liraglutide Consumption 2019-2024 (K Units)
Figure Italy Liraglutide Value 2019-2024 ($ Millions)
Figure Russia Liraglutide Consumption 2019-2024 (K Units)
Figure Russia Liraglutide Value 2019-2024 ($ Millions)
Figure Spain Liraglutide Consumption 2019-2024 (K Units)
Figure Spain Liraglutide Value 2019-2024 ($ Millions)
Figure Egypt Liraglutide Consumption 2019-2024 (K Units)
Figure Egypt Liraglutide Value 2019-2024 ($ Millions)
Figure South Africa Liraglutide Consumption 2019-2024 (K Units)
Figure South Africa Liraglutide Value 2019-2024 ($ Millions)
Figure Israel Liraglutide Consumption 2019-2024 (K Units)
Figure Israel Liraglutide Value 2019-2024 ($ Millions)
Figure Turkey Liraglutide Consumption 2019-2024 (K Units)
Figure Turkey Liraglutide Value 2019-2024 ($ Millions)
Figure GCC Countries Liraglutide Consumption 2019-2024 (K Units)
Figure GCC Countries Liraglutide Value 2019-2024 ($ Millions)
Table Global Liraglutide Consumption Forecast by Type (2019-2024) (K Units)
Table Global Liraglutide Consumption Market Share Forecast by Type (2019-2024)
Table Global Liraglutide Value Forecast by Type (2019-2024) ($ Millions)
Table Global Liraglutide Value Market Share Forecast by Type (2019-2024)
Table Global Liraglutide Consumption Forecast by Application (2019-2024) (K Units)
Table Global Liraglutide Consumption Market Share Forecast by Application (2019-2024)
Table Global Liraglutide Value Forecast by Application (2019-2024) ($ Millions)
Table Global Liraglutide Value Market Share Forecast by Application (2019-2024)
Table HEC Pharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table HEC Pharm Liraglutide Sales, Revenue, Price and Gross Margin (2017-2019)
Figure HEC Pharm Liraglutide Market Share (2017-2019)
Table Bachem Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bachem Liraglutide Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Bachem Liraglutide Market Share (2017-2019)
Table Bharat Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bharat Pharmaceuticals Liraglutide Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Bharat Pharmaceuticals Liraglutide Market Share (2017-2019)
Table Kingpep Biotechnology Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kingpep Biotechnology Liraglutide Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Kingpep Biotechnology Liraglutide Market Share (2017-2019)
Table Shenzhen JYMed Technology Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shenzhen JYMed Technology Liraglutide Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Shenzhen JYMed Technology Liraglutide Market Share (2017-2019)
Table Wuxi Asiapeptide Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Wuxi Asiapeptide Liraglutide Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Wuxi Asiapeptide Liraglutide Market Share (2017-2019)
Table AmbioPharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AmbioPharm Liraglutide Sales, Revenue, Price and Gross Margin (2017-2019)
Figure AmbioPharm Liraglutide Market Share (2017-2019)
  • Global Alpha-Glucosidase Inhibitors Industry Market Research Report
    Published: 17-Oct-2019        Price: US 2960 Onwards        Pages: 110
    The Alpha-Glucosidase Inhibitors market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Alpha-Glucosidase Inhibitors industrial chain, this report mainly elaborates the definition, types, applications and major players of Alpha-Glucosidase Inhibitors market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of ......
  • Global Diabetes Drug Industry Market Research Report
    Published: 17-Oct-2019        Price: US 2960 Onwards        Pages: 117
    The Diabetes Drug market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Diabetes Drug industrial chain, this report mainly elaborates the definition, types, applications and major players of Diabetes Drug market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development tre......
  • Global Insulin API Market Study 2016-2026, by Segment (Regular Human Insulin, Insulin Analogue) , by Market (Short Acting Insulin, Intermediate Acting Insulin,) , by Company (Novo Nordisk, Eli Lilly,)
    Published: 15-Oct-2019        Price: US 1800 Onwards        Pages: 53
    Summary The global Insulin API market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Regular Human Insulin - Insulin Analogue Demand Coverage (Market Size & Forecast, Consumer Distribution): - Short Acting Insulin - Intermediate Acting Insulin - Long Acting Insulin - Pre-Mix Insulin ......
  • Global Human Insulin Market Study 2016-2026, by Segment (Short Acting Human Insulin, Intermediate Acting Human Insulin,) , by Market (Insulin Dependent Diabetes Mellitus, Non-Insulin Dependent Diabetes Mellitus) , by Company (Sanofi (France) , Eli Lilly and Company (U.S.) ,)
    Published: 13-Oct-2019        Price: US 1800 Onwards        Pages: 53
    Summary The global Human Insulin market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Short Acting Human Insulin - Intermediate Acting Human Insulin - Premixed Human Insulin Demand Coverage (Market Size & Forecast, Consumer Distribution): - Insulin Dependent Diabetes Mellitus - Non-Insulin Dependent Di......
  • Global Incretin-Based Drugs Market Professional Survey Report 2019
    Published: 08-Oct-2019        Price: US 3500 Onwards        Pages: 102
    Incretins are gut derived hormones, released after the ingestion of food. Incretins are classified into glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Both the molecules are inactivated by enzyme Dipeptidyl Peptidase-4 (DPP-4). Oral traditional anti-diabetic drugs, often fail to maintain the desired normal level of glucose, especially in the postprandial condition. This has resulted in a strong need for better therapeutics such as incretin based drugs. ......
  • Global Human Insulin Market Professional Survey Report 2019
    Published: 04-Oct-2019        Price: US 3500 Onwards        Pages: 103
    Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans. In 2018, North America is estimated to dominate the global human insulin market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulator......
  • Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Professional Survey Report 2019
    Published: 04-Oct-2019        Price: US 3500 Onwards        Pages: 103
    Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and are used in the treatment of type 2 diabetes. The global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Dipeptidyl Peptidase-4 (DPP-4) Inhibitors volume and value at global level, regional level and company level. F......
  • Global Antidiabetics Market Professional Survey Report 2019
    Published: 30-Sep-2019        Price: US 3500 Onwards        Pages: 105
    Type 1 Diabetes and Type 2 Diabetes are common types of diabetes. Treatments include (1) agents that increase the amount of insulin secreted by the pancreas, (2) agents that increase the sensitivity of target organs to insulin, and (3) agents that decrease the rate at which glucose is absorbed from the gastrointestinal tract. The North American antidiabetics market held the largest market revenue share in 2013. High market penetration of modern insulin products such as long-acting, rapid ......
  • Global Lixisenatide Market Professional Survey Report 2019
    Published: 26-Sep-2019        Price: US 3500 Onwards        Pages: 107
    Lixisenatide is a once-daily injectable GLP-1 receptor agonist for the treatment of diabetes type II.  The growth of the global lixisenatide market is driven by increase in prevalence diabetes and surge in overweight populace. Moreover, unhealthy urban lifestyle and increase number of fast food eating populace susceptible to sudden weight gain are expected to boost the market growth. However, number of limited manufacturers and distribution channels is anticipated to imped......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs